nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethasone—CYP3A4—Rosuvastatin—atherosclerosis	0.193	0.211	CbGbCtD
Paramethasone—CYP3A4—Ezetimibe—atherosclerosis	0.193	0.211	CbGbCtD
Paramethasone—CYP3A4—Simvastatin—atherosclerosis	0.18	0.196	CbGbCtD
Paramethasone—CYP3A4—Pravastatin—atherosclerosis	0.176	0.192	CbGbCtD
Paramethasone—CYP3A4—Lovastatin—atherosclerosis	0.176	0.192	CbGbCtD
Paramethasone—Betamethasone—PLA2G1B—atherosclerosis	0.00594	0.43	CrCbGaD
Paramethasone—CYP3A4—Irinotecan Pathway—NPC1—atherosclerosis	0.00442	0.0638	CbGpPWpGaD
Paramethasone—Dexamethasone—PLA2G1B—atherosclerosis	0.00345	0.25	CrCbGaD
Paramethasone—CYP3A4—Liver X Receptor Pathway—ABCG8—atherosclerosis	0.00304	0.0439	CbGpPWpGaD
Paramethasone—CYP3A4—Liver X Receptor Pathway—CYP7A1—atherosclerosis	0.00218	0.0315	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.00192	0.0277	CbGpPWpGaD
Paramethasone—CYP3A4—Liver X Receptor Pathway—ABCG5—atherosclerosis	0.00189	0.0272	CbGpPWpGaD
Paramethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.00154	0.0223	CbGpPWpGaD
Paramethasone—Dexamethasone—NOS2—atherosclerosis	0.00154	0.112	CrCbGaD
Paramethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.00146	0.0211	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.00144	0.0208	CbGpPWpGaD
Paramethasone—CYP3A4—Drug Induction of Bile Acid Pathway—CYP7A1—atherosclerosis	0.00143	0.0206	CbGpPWpGaD
Paramethasone—CYP3A4—Farnesoid X Receptor  Pathway—CYP7A1—atherosclerosis	0.0013	0.0188	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.00121	0.0175	CbGpPWpGaD
Paramethasone—CYP3A4—Aflatoxin B1 metabolism—GSTM1—atherosclerosis	0.0012	0.0173	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.00119	0.0172	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—RETN—atherosclerosis	0.00118	0.017	CbGpPWpGaD
Paramethasone—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.00112	0.0162	CbGpPWpGaD
Paramethasone—NR3C1—Circadian Clock—F7—atherosclerosis	0.00107	0.0154	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.00104	0.015	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000956	0.0138	CbGpPWpGaD
Paramethasone—Triamcinolone—PTGS2—atherosclerosis	0.000929	0.0672	CrCbGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.000911	0.0132	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000903	0.013	CbGpPWpGaD
Paramethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.000827	0.0119	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000819	0.0118	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.00081	0.0117	CbGpPWpGaD
Paramethasone—Betamethasone—PTGS2—atherosclerosis	0.000761	0.0551	CrCbGaD
Paramethasone—Prednisone—ALB—atherosclerosis	0.000751	0.0543	CrCbGaD
Paramethasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000747	0.0108	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000734	0.0106	CbGpPWpGaD
Paramethasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000734	0.0106	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000708	0.0102	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.000696	0.01	CbGpPWpGaD
Paramethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000683	0.00986	CbGpPWpGaD
Paramethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000676	0.00975	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000669	0.00966	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—AHR—atherosclerosis	0.000647	0.00933	CbGpPWpGaD
Paramethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000645	0.0093	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.00064	0.00924	CbGpPWpGaD
Paramethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000616	0.00889	CbGpPWpGaD
Paramethasone—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000603	0.0087	CbGpPWpGaD
Paramethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000584	0.00843	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.00058	0.00837	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.00058	0.00837	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000575	0.00829	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000573	0.00827	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000565	0.00816	CbGpPWpGaD
Paramethasone—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000562	0.00811	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.00055	0.00795	CbGpPWpGaD
Paramethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000535	0.00773	CbGpPWpGaD
Paramethasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.000529	0.00764	CbGpPWpGaD
Paramethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.00052	0.0075	CbGpPWpGaD
Paramethasone—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000513	0.0074	CbGpPWpGaD
Paramethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.00051	0.00736	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000487	0.00703	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.000481	0.00694	CbGpPWpGaD
Paramethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.00048	0.00693	CbGpPWpGaD
Paramethasone—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000474	0.00684	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.000463	0.00668	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.00045	0.0065	CbGpPWpGaD
Paramethasone—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000449	0.00648	CbGpPWpGaD
Paramethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000444	0.00641	CbGpPWpGaD
Paramethasone—Dexamethasone—PTGS2—atherosclerosis	0.000443	0.032	CrCbGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.000429	0.0062	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000423	0.0061	CbGpPWpGaD
Paramethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000421	0.00608	CbGpPWpGaD
Paramethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.0004	0.00578	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.000396	0.00572	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000391	0.00564	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.00039	0.00563	CbGpPWpGaD
Paramethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000389	0.00562	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000385	0.00555	CbGpPWpGaD
Paramethasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000344	0.00497	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000343	0.00495	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000337	0.00486	CbGpPWpGaD
Paramethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	0.000329	0.00475	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000313	0.00452	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000303	0.00437	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000302	0.00436	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000297	0.00429	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000293	0.00423	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000293	0.00423	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000287	0.00415	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000283	0.00409	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000276	0.00398	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.00025	0.00361	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000247	0.00357	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—INS—atherosclerosis	0.000245	0.00354	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000243	0.0035	CbGpPWpGaD
Paramethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000242	0.0035	CbGpPWpGaD
Paramethasone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000239	0.00345	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000237	0.00343	CbGpPWpGaD
Paramethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000235	0.0034	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000234	0.00337	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.000225	0.00325	CbGpPWpGaD
Paramethasone—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	0.000224	0.00323	CbGpPWpGaD
Paramethasone—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000221	0.00319	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000212	0.00306	CbGpPWpGaD
Paramethasone—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	0.000207	0.00299	CbGpPWpGaD
Paramethasone—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000204	0.00294	CbGpPWpGaD
Paramethasone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	0.000176	0.00254	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	0.000174	0.00252	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	0.000165	0.00238	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000165	0.00238	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000158	0.00228	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	0.000155	0.00224	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—STAT3—atherosclerosis	0.000154	0.00222	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000148	0.00213	CbGpPWpGaD
Paramethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000144	0.00209	CbGpPWpGaD
Paramethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	0.000143	0.00206	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	0.000142	0.00205	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	0.000134	0.00193	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—TNF—atherosclerosis	0.000133	0.00192	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	0.000115	0.00166	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	0.000111	0.0016	CbGpPWpGaD
Paramethasone—NR3C1—Adipogenesis—IL6—atherosclerosis	0.000107	0.00155	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	0.0001	0.00145	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	9.42e-05	0.00136	CbGpPWpGaD
Paramethasone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	9.27e-05	0.00134	CbGpPWpGaD
Paramethasone—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	9.24e-05	0.00133	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	9.14e-05	0.00132	CbGpPWpGaD
Paramethasone—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	9.11e-05	0.00132	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—PARP1—atherosclerosis	8.4e-05	0.00121	CbGpPWpGaD
Paramethasone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	8.23e-05	0.00119	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—ESR2—atherosclerosis	7.95e-05	0.00115	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	6.55e-05	0.000946	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—SIRT1—atherosclerosis	6.4e-05	0.000924	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PLTP—atherosclerosis	6.16e-05	0.000889	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.34e-05	0.000771	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.34e-05	0.000771	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—PPARA—atherosclerosis	5.32e-05	0.000768	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—ESR1—atherosclerosis	4.82e-05	0.000696	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—PPARG—atherosclerosis	4.4e-05	0.000635	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.22e-05	0.000609	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LCAT—atherosclerosis	3.97e-05	0.000573	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—FABP4—atherosclerosis	3.97e-05	0.000573	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	3.96e-05	0.000572	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOA4—atherosclerosis	3.9e-05	0.000562	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.83e-05	0.000552	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.54e-05	0.000511	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.35e-05	0.000484	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOA2—atherosclerosis	3.35e-05	0.000484	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.35e-05	0.000484	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.35e-05	0.000484	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.31e-05	0.000478	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LPA—atherosclerosis	3.2e-05	0.000462	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—BGN—atherosclerosis	3.1e-05	0.000447	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOA5—atherosclerosis	3.07e-05	0.000443	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.95e-05	0.000426	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.85e-05	0.000412	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—MAPK3—atherosclerosis	2.58e-05	0.000372	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.56e-05	0.000369	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LIPC—atherosclerosis	2.54e-05	0.000367	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOC3—atherosclerosis	2.53e-05	0.000365	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LDLR—atherosclerosis	2.51e-05	0.000362	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—CETP—atherosclerosis	2.45e-05	0.000354	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.35e-05	0.000339	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.22e-05	0.00032	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.98e-05	0.000285	CbGpPWpGaD
Paramethasone—NR3C1—Gene Expression—AKT1—atherosclerosis	1.74e-05	0.000251	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.7e-05	0.000245	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOB—atherosclerosis	1.62e-05	0.000234	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.58e-05	0.000228	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—LPL—atherosclerosis	1.55e-05	0.000224	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—GPX1—atherosclerosis	1.51e-05	0.000218	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—CD36—atherosclerosis	1.47e-05	0.000213	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.4e-05	0.000202	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PPARA—atherosclerosis	1.37e-05	0.000198	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—AGT—atherosclerosis	1.33e-05	0.000192	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOE—atherosclerosis	1.3e-05	0.000188	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—CAV1—atherosclerosis	1.29e-05	0.000186	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—APOA1—atherosclerosis	1.29e-05	0.000185	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.17e-05	0.000169	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PPARG—atherosclerosis	1.13e-05	0.000163	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—INS—atherosclerosis	1.11e-05	0.00016	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—ALB—atherosclerosis	1.02e-05	0.000147	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—NOS3—atherosclerosis	9.74e-06	0.000141	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.91e-06	0.000129	CbGpPWpGaD
Paramethasone—CYP3A4—Metabolism—AKT1—atherosclerosis	4.48e-06	6.46e-05	CbGpPWpGaD
